102 related articles for article (PubMed ID: 10094882)
21. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
22. Characterization of ten newly-derived human head and neck squamous carcinoma cell lines with special reference to c-erbB proto-oncogene expression.
O-Charoenrat P; Rhys-Evans P; Eccles S
Anticancer Res; 2001; 21(3B):1953-63. PubMed ID: 11497283
[TBL] [Abstract][Full Text] [Related]
23. [Aspects of Bcl-2 proto-oncogene expression in dysplastic and malignant lesions of the uterine cervix].
Borţun F; Chiovschi S; Moldovan M
Rev Med Chir Soc Med Nat Iasi; 2004; 108(4):821-6. PubMed ID: 16004225
[TBL] [Abstract][Full Text] [Related]
24. Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix.
Lee CM; Shrieve DC; Zempolich KA; Lee RJ; Hammond E; Handrahan DL; Gaffney DK
Gynecol Oncol; 2005 Nov; 99(2):415-21. PubMed ID: 16157365
[TBL] [Abstract][Full Text] [Related]
25. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R
Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304
[TBL] [Abstract][Full Text] [Related]
26. Gene profiling in Pap-cell smears of high-risk human papillomavirus-positive squamous cervical carcinoma.
Manavi M; Hudelist G; Fink-Retter A; Gschwandtler-Kaulich D; Pischinger K; Czerwenka K
Gynecol Oncol; 2007 May; 105(2):418-26. PubMed ID: 17306351
[TBL] [Abstract][Full Text] [Related]
27. Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation.
Contessa JN; Abell A; Mikkelsen RB; Valerie K; Schmidt-Ullrich RK
Breast Cancer Res Treat; 2006 Jan; 95(1):17-27. PubMed ID: 16267617
[TBL] [Abstract][Full Text] [Related]
28. Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients.
Bei R; Budillon A; Masuelli L; Cereda V; Vitolo D; Di Gennaro E; Ripavecchia V; Palumbo C; Ionna F; Losito S; Modesti A; Kraus MH; Muraro R
J Pathol; 2004 Nov; 204(3):317-25. PubMed ID: 15476268
[TBL] [Abstract][Full Text] [Related]
29. Oncoprotein c-erbB-2 in squamous cell carcinoma of the uterine cervix and evaluation of its significance in response of disease to treatment.
Bhadauria M; Ray A; Grover RK; Sharma S; Naik SL; Sharma BK
Indian J Physiol Pharmacol; 2001 Apr; 45(2):191-8. PubMed ID: 11480225
[TBL] [Abstract][Full Text] [Related]
30. Expression of bcl-2, bax-xL, and bcl-xS in endometrial and cervical tissues.
Mozzetti S; Ferrandina G; Marone M; D'Ingiullo F; Fruscella E; De Pasqua A; Mancuso S; Scambia G
Cancer Detect Prev; 2000; 24(6):536-41. PubMed ID: 11198267
[TBL] [Abstract][Full Text] [Related]
31. ErbB kinases and NDF signaling in human prostate cancer cells.
Grasso AW; Wen D; Miller CM; Rhim JS; Pretlow TG; Kung HJ
Oncogene; 1997 Nov; 15(22):2705-16. PubMed ID: 9400997
[TBL] [Abstract][Full Text] [Related]
32. Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members.
Xia W; Lau YK; Zhang HZ; Xiao FY; Johnston DA; Liu AR; Li L; Katz RL; Hung MC
Clin Cancer Res; 1999 Dec; 5(12):4164-74. PubMed ID: 10632356
[TBL] [Abstract][Full Text] [Related]
33. Apoptosis and the expression of Bax and Bcl-2 in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
Kokawa K; Shikone T; Otani T; Nakano R
Cancer; 1999 Apr; 85(8):1799-809. PubMed ID: 10223575
[TBL] [Abstract][Full Text] [Related]
34. Unusual c-KIT (+) squamous cell carcinoma of uterine cervix showing remarkable platelet-derived growth factor receptor, alpha subunit expression, but no activating mutation.
Han CP; Chen CK; Lin CK; Wang PH; Chiang H
Histopathology; 2011 Oct; 59(4):788-90. PubMed ID: 22014059
[No Abstract] [Full Text] [Related]
35. Expression of ErbB-3 and ErbB-4 protooncogene proteins in oral squamous cell carcinoma: a pilot study.
de Vicente JC; Esteban I; Germanà P; Germanà A; Vega JA
Med Oral; 2003; 8(5):374-81. PubMed ID: 14595263
[TBL] [Abstract][Full Text] [Related]
36. The expression of HPV-16 E5 protein in squamous neoplastic changes in the uterine cervix.
Chang JL; Tsao YP; Liu DW; Huang SJ; Lee WH; Chen SL
J Biomed Sci; 2001; 8(2):206-13. PubMed ID: 11287752
[TBL] [Abstract][Full Text] [Related]
37. c-erbB-2 oncoprotein and epidermal growth factor receptor in cervical lesions.
Lakshmi S; Nair MB; Jayaprakash PG; Rajalekshmy TN; Nair MK; Pillai MR
Pathobiology; 1997; 65(3):163-8. PubMed ID: 9309783
[TBL] [Abstract][Full Text] [Related]
38. Cooverexpression of ERBB1 and ERBB4 receptors predicts poor clinical outcome in pN+ oral squamous cell carcinoma with extranodal spread.
Silva SD; Alaoui-Jamali MA; Hier M; Soares FA; Graner E; Kowalski LP
Clin Exp Metastasis; 2014 Mar; 31(3):307-16. PubMed ID: 24338375
[TBL] [Abstract][Full Text] [Related]
39. Co-localization of multiple ErbB receptors in stratified epithelium of oral squamous cell carcinoma.
Bei R; Pompa G; Vitolo D; Moriconi E; Ciocci L; Quaranta M; Frati L; Kraus MH; Muraro R
J Pathol; 2001 Oct; 195(3):343-8. PubMed ID: 11673832
[TBL] [Abstract][Full Text] [Related]
40. Expression of the proto-oncogene bcl-2 in uterine cervical squamous cell carcinoma: its relationship to clinical outcome.
Uehara T; Kuwashima Y; Izumo T; Kishi K; Shiromizu K; Matsuzawa M
Eur J Gynaecol Oncol; 1995; 16(6):453-60. PubMed ID: 8536760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
